Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
alector
alkermes
ally bridge group
avrobio
baricitinib
bcma
big data analytics
biotech
blackrock
bolt biotherapeutics
boston
boulder/denver blog main
boulder/denver top stories
caribou biosciences
casdin capital
celgene
congress
crispr
darzalex
depression
detroit blog main
detroit top stories
diabetic nephropathy
drugs
duchenne muscular dystrophy
eli lilly
eventide asset management
fda
focal segmental glomerulosclerosis
ge ventures
gene editing
gene therapy
genentech
gilead sciences
What
bio
later
2
×
new
2
×
analysis
biopharma
biotech
bring
company
congress
congressional
crispr
develop
diseases
drug
employing
executives
feud
genetic
goldfinch
group
ipo
isn’t
kidney
known
lead
medicines
million
month
ny
pharma
raised
raises
roster
roundup
spectacles
splash
stay
studies
testify
tuned
Language
unset
Current search:
later
×
new
×
" boston top stories "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
